[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359590-105":59,"doc-detail-359590-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-an-m7g-related-lncrna-signature-for-prognostic-prediction-and-immune-landscape-characterization-in-early-gastric-cancer","Identification of an m7G-Related lncRNA Signature for Prognostic Prediction and Immune Landscape Characterization in Early Gastric Cancer","","Early gastric cancer (EGC) generally has a favorable prognosis, yet clinical outcomes vary substantially and reliable biomarkers are lacking to identify high-risk patients for personalized therapy. Using TCGA-EGC data, researchers identified prognostic m7G-related long non-coding RNAs and built a six-lncRNA risk model via univariate Cox and LASSO, validated by qRT-PCR. Survival, ROC, multivariate Cox, GSEA, immune infiltration, TMB, and drug-sensitivity analyses assessed prognostic performance and immune- and pathway-level biology, showing distinct high- vs low-risk immune microenvironments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-an-m7g-related-lncrna-signature-for-prognostic-prediction-and-immune-landscape-characterization-in-early-gastric-cancer/359590/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-an-m7g-related-lncrna-signature-for-prognostic-prediction-and-immune-landscape-characterization-in-early-gastric-cancer/359590.png","ImageObject",300,407,{"name":92,"@type":93},"WPS_1786070896","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was the m7G-related lncRNA prognostic signature constructed and validated?","Question",{"text":112,"@type":113},"The signature was identified from TCGA-EGC data, built using univariate Cox and LASSO, and gene expression was further validated by qRT-PCR.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the six-lncRNA risk model show for patient prognosis?",{"text":117,"@type":113},"The model stratifies EGC patients into high- and low-risk groups with significantly different overall survival, and the risk score is an independent prognostic factor in univariate and multivariate Cox analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the immune landscape and tumor mutation burden linked to the risk score?",{"text":121,"@type":113},"High-risk patients show an immunosuppressive tumor microenvironment associated with immune escape. TMB is negatively correlated with the risk score, and high-risk with low TMB corresponds to the poorest prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359590,1790545633,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},549768072016,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","OncoTargets and Therapy  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nIdentification of an m7G-Related lncRNA Signature for Prognostic Prediction and Immune Landscape Characterization in Early Gastric Cancer  \nYuan Zhang 1 , Hongmei Cai2 , Kaige Yin 1 , Li Liu 1 , Mingshuang Yang 1 , Chenguang Ji 1  \n1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China; 2Deparment of Oncology, Hebei Chest Hospital, Shijiazhuang, Hebei, People’s Republic of China  \nCorrespondence: Chenguang Ji, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China, Tel +86-13833196682, Email [chenguangji@yeah.net](chenguangji@yeah.net)  \n\n| Background: While early gastric cancer (EGC) is generally associated with a favorable prognosis, its clinical outcomes are notably heterogeneous. Unlike advanced gastric cancer requiring uniform intensive treatment, EGC lacks robust biomarkers to identify highrisk patients for personalized therapy. Although both N7-methylguanosine (m7G) modification and long non-coding RNAs (lncRNAs) are involved in tumorigenesis, the prognostic value of m7G-related lncRNAs in EGC remains poorly defined.\u003Cbr>Methods: Based on TCGA-EGC data, we identified m7G-related lncRNAs with prognostic significance and constructed a prognostic model for m7G-related lncRNAs using univariate Cox and LASSO. The expression of the model genes was further validated by qRTPCR. A series of statistical and bioinformatic analyses, including survival analysis, ROC curves, multivariate Cox regression, GSEA, immune infiltration, tumor mutation burden (TMB), and drug sensitivity assays, were performed to evaluate the prognostic performance and underlying biological characteristics of the signature.\u003Cbr>Results: A six-m7G-related-lncRNA risk model effectively stratified EGC patients into high-and low-risk groups with significantly distinct overall survival. The risk score was confirmed as an independent prognostic factor by univariate and multivariate Cox analysis. Pathway differences between risk groups were primarily enriched in tumor microenvironment regulation terms. Notably, the high-risk group exhibited an immunosuppressive tumor microenvironment correlated with immune escape. TMB analysis showed a negative correlation between the risk score and TMB, with the high-risk and low-TMB subgroup exhibiting the poorest prognosis. In silico drug sensitivity analysis further suggested that high-risk patients may develop poorer sensitivity to five clinical drugs, including Cisplatin, Oxaliplatin, and Vinorelbine.\u003Cbr>Conclusion: The six-m7G-related-lncRNA signature represents a promising prognostic tool for EGC that may facilitate personalized risk stratification and guide clinical decision-making regarding adjuvant or immunotherapeutic strategies.\u003Cbr>Keywords: early gastric cancer, m7G, lncRNA, prognostic signature, immune infiltration |\n| --- |\n| Introduction\u003Cbr>Gastric cancer (GC) remains a formidable global health challenge, ranking as the fifth most common malignancy and the fourth leading cause of cancer-related deaths worldwide.1,2 With advances in diagnostic techniques and the widespread adoption of health screening programs, the proportion of patients diagnosed with early gastric cancer (EGC), confined to the mucosa or submucosa regardless of lymph node metastasis, has steadily increased.3 The symptoms of EGC often overlap with those of common benign conditions (chronic gastritis or dyspepsia) and are easily overlooked by both patients and clinicians.4 Common symptoms include mild epigastric discomfort, bloating, belching, acid reflux, loss of appetite, and mild nausea.5 Currently, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) have become the preferred methods for treating low-risk EGC that meets specific criteria, owing to their |\n\n[https://doi.org/10.2147/OTT.S582487](https://do","cbCaikF1sgcVdIVh","https://ap.wps.com/l/cbCaikF1sgcVdIVh","pdf",12177346,16,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"How was the m7G-related lncRNA prognostic signature constructed and validated?\",\"answer\":\"The signature was identified from TCGA-EGC data, built using univariate Cox and LASSO, and gene expression was further validated by qRT-PCR.\"},{\"question\":\"What does the six-lncRNA risk model show for patient prognosis?\",\"answer\":\"The model stratifies EGC patients into high- and low-risk groups with significantly different overall survival, and the risk score is an independent prognostic factor in univariate and multivariate Cox analyses.\"},{\"question\":\"How is the immune landscape and tumor mutation burden linked to the risk score?\",\"answer\":\"High-risk patients show an immunosuppressive tumor microenvironment associated with immune escape. TMB is negatively correlated with the risk score, and high-risk with low TMB corresponds to the poorest prognosis.\"}]","Identification of an m7G-Related lncRNA Signature for Prognostic Prediction and Immune Landscape Characterization in Early Gastric Cancer | PDF",1790137233,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83a18bbbcf31b0a2384d80877f08faba.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d96a8e4295196da44437fd1e863ab918.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c404eb886e4723084bc0290d2f7ec8b.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8b85960e9a4c8626f4c61afa002da7a.webp",980,1268]